VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the syndicate of investors on the deal. Tagworks Pharmaceuticals BV announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised a syndicate of investors on the deal. Bird & Bird advised SparingVision. SparingVision, a genomic medicines company with a mission to translate pioneering...
You must be a Standard 1 Year member to access this content.
